Mass Spectrometry in Cerebrospinal Fluid Uncovers Association of Glycolysis Biomarkers with Alzheimer’s Disease in a Large Clinical Sample
Matthijs B. de Geus(Leiden University Medical Center), Becky C. Carlyle(University of Oxford)
Cited by 3
Related Papers
Transcriptome and epigenome landscape of human cortical development modeled in organoids
|Science|2018|314
Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively unimpaired older adults
|Alzheimer s & Dementia|2021|94
Mass spectrometry in cerebrospinal fluid uncovers association of glycolysis biomarkers with Alzheimer’s disease in a large clinical sample
|Scientific Reports|2023|27
Brain MRI signatures across sex and CSF Alzheimer’s disease biomarkers
|Brain Communications|2025|1